Evaluate the patient care recommandation induced by the IMMUNOSCORE® result
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
100
recommendation for patient care according to the result of the IMMUNOSCORE®
Hôpital Européen
Marseille, France
NOT_YET_RECRUITINGHopital Saint Joseph
Marseille, France
RECRUITINGNumber of cases where the recommendations for patient care according to the Immunoscore® are considered beneficial compared to the standard care decision
Time frame: 5 years
Replication error (RER) phenotype
Number of cases where the Immunoscore® resultat is inconsistent with the RER phenotype
Time frame: 6 and 9 months
KRAS, NRAS and BRAF mutations
Number of cases where the Immunoscore® resultat is inconsistent with the KRAS, NRAS and BRAF mutations
Time frame: 6 and 9 months
Ratio of ciruclating tumor DNA level
Number of cases where the Immunoscore® resultat is inconsistent with the ratio of ciruclating tumor DNA level
Time frame: 6 and 9 months
Actual survival (patient alive without recurrence, alive with recurrence, dead)
Number of cases where the Immunoscore® resultat is inconsistent with the actual survival
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.